Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Opioid-Induced Constipation × Lubiprostone × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 2 Opioid-Induced Constipation 1 Neoplasms 1 Neoplasm Metastasis 1

Interventions

naloxegol 6 tegaserod 3 naldemedine 3 prucalopride 1 methylnaltrexone 1 linaclotide 1 alvimopan 1 Polyethylene Glycols 1 Oxycodone 1 Magnesium Hydroxide 1 Lubiprostone 1 Electrolytes 1 Electroacupuncture 1 Dosage Forms 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03720613 2025-02-12

Risk of Major Adverse Cardiovascular Events for Naldemedine & Other Medications for Opioid Induced Constipation

BioDelivery Sciences International

34,532 enrolled

Opioid-Induced Constipation

Data powered by HemOnc (CC BY 4.0) Colophon ⚡